MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-27-0000288
Qualigens Pharma Private Limited - pharma in Khalapur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹214.78 Cr
▲ 13% YoY
Net profit · FY 2025
₹30.11 Cr
Net margin 14%
EBITDA · FY 2025
₹45.92 Cr
EBITDA margin 21.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.55 Cr
Issued & subscribed
Open charges
₹48.99 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
330
Provident fund records
About Qualigens Pharma Private Limited
Data last updated:
Qualigens Pharma Private Limited is a private limited company based in Khalapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2013PTC249071. Its GSTIN is 27AAACQ3283C1ZN (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.55 Cr. It is led by directors including Ajit Jain and Ankit Suresh Paharia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. 151/2 At Village Umbre Khopoli Pali Road Taluka Khalapur, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹214.78 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹30.11 Cr (net margin 14%) and EBITDA of ₹45.92 Cr (EBITDA margin 21.4%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 42% over five years.
The company has about 330 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Qualigens Pharma. As per MCA filings, the company has open charges of ₹48.99 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.54 Cr; the latest was in March 2020.
Qualigens Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0000288). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qualigenspharma.com.
Company details
CIN U24100MH2013PTC249071
Registration Number 249071
Incorporation Date 10 October 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-27-0000288
Recognitions & Rankings of Qualigens Pharma
Contact details
Qualigens Pharma Private Limited's registered office is in Khalapur, Maharashtra. Its website is qualigenspharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressSurvey No. 151/2 At Village Umbre Khopoli Pali Road Taluka Khalapur, Maharashtra, India – 410206
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Qualigens Pharma Private Limited, buy the company report.
Comprehensive company report
Qualigens Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Qualigens Pharma operates one associated brand: Qualigens Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical tablets, capsules, and formulations for global partners. | qualigenspharma.com |
Business activity
The main business activity of Qualigens Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Qualigens Pharma Private Limited, buy the company report.
Financials of Qualigens Pharma Private Limited
FY 2025 filings availableQualigens Pharma Private Limited reported revenue of ₹214.78 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹214.78 Cr ▲ 13%
Net profit · FY 2025
₹30.11 Cr margin 14%
EBITDA · FY 2025
₹45.92 Cr margin 21.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 40%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 29%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 13% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.4% | ||||
| Net Profit Margin | 14% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Qualigens Pharma Private Limited, buy the company report.
Board of directors of Qualigens Pharma Private Limited
Qualigens Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Jain Also directs: Naulakha Impex LLP, Jinendra Qualipharm Private Limited | Director | 10 Mar 2016 | 10 Years 8 Months | Current |
| Ankit Suresh Paharia Also directs: Bulwark Business Services LLP, Paharia Vintrade LLP, Durlabh Consultancy LLP and 5 more | Director | 10 Oct 2013 | 13 Years 1 Months | Current |
| Aayush Jain Also directs: Naulakha Impex LLP, Jinendra Qualipharm Private Limited, Vakunth Vinimay LLP and 4 more | Director | 01 Aug 2017 | 9 Years 3 Months | Current |
Auditor
Qualigens Pharma Private Limited is audited by JAIN S P AND ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN S P AND ASSOCIATES LLP | FY 2023 | W100239 |
Shareholding
The shareholding of Qualigens Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Qualigens Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹48.99 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2024 | 100963792 | Others | ₹5 Cr | Open | |
| 22 Apr 2021 | 100451504 | Axis Bank Limited | ₹11 Cr | Open | |
| 27 Feb 2020 | 100327151 | Others | ₹2.24 Cr | Open | |
| 17 Jul 2019 | 100275914 | Others | ₹30.75 Cr | Open |
To see the full charge records of Qualigens Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Qualigens Pharma Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.54 Cr; the latest was in March 2020.
Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹1.54 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Funding round | ₹54.8 Lakh | Investors: Vakunth Vinimay LLP , an individual |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: Naulakha Impex LLP Seller: Bulwark Business Services LLP , Munisuvrat Consultancy Private Limited |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Naulakha Impex LLP Seller: Munisuvrat Consultancy Private Limited , Bulwark Business Services LLP |
| Mar 2015 | Funding round | ₹99 Lakh | Investors: Bulwark Business Services LLP , Munisuvrat Consultancy Private Limited , Evergrow Marketing Private Limited |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Bulwark Business Services LLP , Munisuvrat Consultancy Private Limited , Jinendra Qualipharm Private Limited Seller: 2 individuals |
To see the full deal history of Qualigens Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Qualigens Pharma Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by J and S Power Solutions Thruogh Prasanna Mohan Guntanur | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by J and S Power Solutions Thruogh Prasanna Mohan Guntanur | Disposed |
To see the full case history of Qualigens Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qualigens Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Qualigens Pharma Private Limited has a workforce of 330 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
330
Active EPFO establishments
1
Employee growth
24.5%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 330 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Qualigens Pharma Private Limited, buy the company report.
GST
Qualigens Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACQ3283C1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Qualigens Pharma Private Limited, buy the company report.
Recent activity
Qualigens Pharma Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Aayush Jain ceased to be Additional Director on 15 Dec 2020.
AGM
Qualigens Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Qualigens Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 5.00 Cr registered on 24 Jul 2024 with Charge ID 100963792 was modified on 21 Mar 2025.
Charges
A charge with Others of Rs. 30.75 Cr registered on 17 Jul 2019 with Charge ID 100275914 was modified on 21 Mar 2025.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100963792 was registered on 24 Jul 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 11.00 Cr with Charge ID 100451504 was registered on 22 Apr 2021.
Ceased
Aayush Jain ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 2.24 Cr with Charge ID 100327151 was registered on 27 Feb 2020.
Charges
A charge with Others of Rs. 2.24 Cr registered on 27 Feb 2020 with Charge ID 100327151 was modified on 27 Feb 2020.
Charges
A charge with Others amounted to Rs. 30.75 Cr with Charge ID 100275914 was registered on 17 Jul 2019.
Ceased
Sumatiprakash Madanlal Jain ceased to be Director.
Ceased
Suresh Somchand Shah ceased to be Director.
5 earlier events are in the company report.
Frequently asked questions
Qualigens Pharma is an active private limited company based in Khalapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2013 (13+ years old) and is registered under CIN U24100MH2013PTC249071.
Qualigens Pharma has 3 current directors:
- Ajit Jain - Director
- Ankit Suresh Paharia - Director
- Aayush Jain - Director
The latest financial statements of Qualigens Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Qualigens Pharma is 27AAACQ3283C1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Qualigens Pharma is U24100MH2013PTC249071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qualigens Pharma has 2 court cases on record: 2 filed against it. 1 is pending.
Qualigens Pharma was incorporated on 10 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Qualigens Pharma has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.54 Cr; the latest was in March 2020.
Aayush Jain ceased to be Additional Director on 15 Dec 2020. Sumatiprakash Madanlal Jain ceased to be Director on 28 Feb 2019. Suresh Somchand Shah ceased to be Director on 28 Feb 2019. Qualigens Pharma has 7 board changes on record in total.
Yes, Qualigens Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-27-0000288).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages